Anatabine citrate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAnatabine citrate
Drug Alias NameAnatablocRCP-006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsBeta amyloid A4 protein inhibitors
TargetsNuclear factor NF-kappa-B complexBeta amyloid A4 protein
Therapy Area/IndicationsSmoking CessationTobacco Use DisorderInflammation +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesRock CreekRoskamp Institute
China Registration ClassN/A

Develop Information

Active CompaniesRoskamp Institute
Inactive CompaniesRock Creek Pharmaceuticals Inc
Active IndicationsInflammation
Inactive IndicationsSmoking CessationTobacco Use DisorderThyroiditis, Autoimmune +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia